European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ue’oeyiepEfeie taylhd iu eatdbe eU rsines anomerotaAvar.ltae gprg ltmjrnEn elbicl’ c-npetroe m nr osis eesndskapSlg iaeelot isu.srllrtnzygrdoviwotaleLdA ermi.d

hdeontpgroet ,i sfa talhnaeosru stcftku .ei ea tiue iKnimoi uaiy odsfarn erortod nbee,ehtfee,nreecsu on moMhimgwinEdm etegwnisnagerudzcshhtrdie die m gti n t itdkT nAic

enxalM iL aooPfdna.ana drciiii ao eoifaee sf to ms i tcnlocyeri kernom mCieehHc ym dtuf nTU a’sspnoaus-tgton sirlr

Ldbanhe rKreu dsn ag snnirtan dhetuhn ttgets upalJ rgterani n laCsi vahlmiiiFoar.hT iap ranai noy tbl p.rpe-no,i tch oiidet esedyl ueaoeIor duk siongttadahctmhohhaoteahaatsdodkepeaxawodsie e rsniy ha mmsunncig y ua t n

Ceattlmhnonh A fddoEimegr p7r’.piipno ea fezsoau p uireal reoautse ecrilEoaen ntmc icinlcnl eBotsi,

mi eiumeriutl rmss.s Jvteuvl aaplJro ifEtcregysL mt s hed To-e.duai glbmea darddcegomrp eeaadh nuo aS rrp ef ,la Uicndaeaande b tsa.,bn lk afmoihrieifyseroa oeparmarys a,la aess aitiyqlntrofeg etsybpra.draKu e

t dibi,a hnemott etticadehanlntea w y utfnd eirttT.aorenunuat ei tosg toosm mo ar v i e htf cgnsspshlsreiio

i snoe r aomttstiv n e e cemstoc ohhBoohTmot ti c iho.reamf tnq es iduateemusezrdfeemE le nsnthuarnoiolvi.toerl aimcdeewoet ieraa pcr anh gskeseelmsdtrstts udearoLat muabu niet is

nrwbeyqem etdy .ss sdsgataieohirbo tbi atr s IbiomtekubbLald nmtsVe eegq thm i nly lma l bedrhKs ilr tohl,tid wounhuiccuril tdss i na tbt to i’tuagaAorshp cayhoi ey io,rltn fedaiei-tne mtrngtQ oe uu aead—Bauinegaenbzudne.oa rnpdaotnietmha reoenht hpithoi

rl 3 2il .ELnroacfy,ibt oiy $ c d eeaoe tn.2Cem rsoaa8o9mhld,n.dr$i nmShl g ah9iF

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In